Management strategies for colorectal liver metastases - Part II

Surgical Oncology

Volumn 6, Issue 1, 1997, Pages 31-48

  Hugh, Thomas J ^a   Kinsella, Anne R ^b   Poston, Graeme J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Colorectal cancer; Hepatic artery infusion; Hepatic cryotherapy; Liver metastases; Liver resection; Prognostic factors

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; RALTITREXED;

AGE; ARTIFICIAL EMBOLISM; BLEEDING; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CRYOTHERAPY; GENE THERAPY; HEPATIC ARTERY; HORMONAL THERAPY; HUMAN; IMMUNOTHERAPY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER PERFUSION; LIVER RESECTION; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE;

EID: 0030830612     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(97)00003-0     Document Type: Review

References (149)

1. Scheele J., Stang R., Altendorfhofmann A. and Paul M. Resection of colorectal liver metastases. World Journal of Surgery 1995, 19, 59-71.
2. Bruinvels D. J., de-Brauw L. M., Kievit J., Habbema J. D. and van-de-Velde C. J. Attitudes towards detection and management of hepatic metastases of colorectal origin: a second look. HPB Surgery 1994, 8, 115-122.
3. Woodington G. F. and Waugh J. M. Results of resection of metastatic tumors of the liver. American Journal of Surgery 1963, 105, 24-29.
4. Flanagan L. and Foster J. H. Hepatic resection for metastatic cancer. American Journal of Surgery 1967, 113, 551-557.
5. Wilson S. M. and Adson M. A. Surgical treatment of hepatic metastases from colorectal cancers. Archives of Surgery 1976, 111, 330-334.
6. Wanebo H. J., Semoglou C., Attiyeh F. and Stearns M. J. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. American Journal of Surgery 1978, 135, 81-85.
7. Thompson H. H., Tompkins R. K. and Longmire W. P. Major hepatic resection - a 25-year experience. Annals of Surgery 1983, 197, 375-388.
8. Rajpal S., Dasmahapatra K. S., Ledesma E. J. and Mittelman A. Extensive resections of isolated metastasis from carcinoma of the colon and rectum. Surgical Gynecology and Obstetrics 1982, 155, 813-816.
9. Logan S. E., Meier S. J., Ramming K. P., Morton D. L. and Longmire W. P. Hepatic resection of metastatic colorectal carcinoma - a 10-year experience. Archives of Surgery 1982, 117, 25-28.
10. Morrow C. E., Grage T. B., Sutherland D. E. R. and Najarian J. S. Hepatic resection for secondary neoplasms. Surgery 1982, 92, 610-614.
11. Fortner J. G., Silva J. S., Golbey R. B., Cox E. B. and Maclean B. J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer-1. Treatment by hepatic resection. Annals of Surgery 1984, 199, 306-316.
12. Adson M. A., Vanheerden J. A., Adson M. H., Wagner J. S. and Ilstrup D. M. Resection of hepatic metastases from colorectal cancer. Archives of Surgery 1984, 119, 647-651.
13. Petrelli N. J., Nambisan R. N., Herrera L. and Mittelman A. Hepatic resection for isolated metastasis from colorectal carcinoma. American Journal of Surgery 1985, 149, 205-209.
14. Coppa G. F., Eng K., Ranson J. H. C., Gouge T. H. and Localio S. A. Hepatic resection for metastatic colon and rectal cancer - an evaluation of preoperative and post-operative factors. Annals of Surgery 1985, 202, 203-208.
15. Cady B. and McDermott W. V. Major hepatic resection for metachronous metastases from colon cancer. Annals of Surgery 1985, 201, 204-209.
16. Butler J., Attiyeh F. F. and Daly J. M. Hepatic resection for metastases of the colon and rectum. Surgical Gynecology and Obstetrics 1986, 162, 109-113.
17. Ekberg H., Tranberg K. G., Andersson R., Lundstedt C., Hagerstrand I., Ranstam J., et al. Determinants of survival in liver resection for colorectal secondaries. British Journal of Surgery 1986, 73, 727-731.
18. Iwatsuki S., Esquivel C. O., Gordon R. D. and Starzl T. E. Liver resection for metastatic colorectal cancer. Surgery 1986, 100, 804-810.
19. Gennari L., Doci R., Bozzetti F. and Bignami P. Surgical treatment of hepatic metastases from colorectal cancer. Annals of Surgery 1986, 203, 49-54
20. Cobourn C. S., Makowka L., Langer B., Taylor B. R. and Falk R. E. Examination of patient selection and outcome for hepatic resection for metastatic disease. Surgical Gynecology and Obstetrics 1987, 165, 239-246.
21. Nordlinger B., Pare R., Delva E., Quilichini M. A., Hannoun L. and Huguet C. Hepatic resection for colorectal liver metastases - influence on survival of preoperative factors and surgery for recurrences in 80 patients. Annals of Surgery 1987, 205, 256-263.
22. Attiyeh F. F. and Wichern W. A. Hepatic resection for primary and metastatic tumors. American Journal of Surgery 1988, 156, 368-372.
23. Bismuth H., Castaing D. and Garden O. J. Major hepatic resection under total vascular exclusion. Annals of Surgery 1989, 210, 13-19.
24. Hughes K. S., Rosenstein R. B., Songhorabodi S., Adson M. A., Ilstrup D. M., Fortner J. G., et al. Resection of the liver for colorectal carcinoma metastases - a multi-institutional study of long-term survivors. Diseases of the Colon and Rectum 1988, 31, 1-4.
25. Holm A., Bradley E. and Aldrete J. S. Hepatic resection of metastasis from colorectal carcinoma - morbidity, mortality, and pattern of recurrence. Annals of Surgery 1989, 209, 428-434.
26. Lise M., Dapian P. P., Nitti D., Pilati P. L. and Prevaldi C. Colorectal metastases to the liver - present status of management. Diseases of the Colon and Rectum 1990, 33, 688-694.
27. Scheele J., Stangl R., Altendorfhofmann A. and Gall F. P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991, 110, 13-29.
28. Vogt P., Raab R., Ringe B. and Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World Journal of Surgery 1991, 15, 62-67.
29. Doci R., Gennari L., Bignami P., Montalto F., Morabito A. and Bozzetti F. 100 patients with hepatic metastases from colorectal cancer treated by resection - analysis of prognostic determinants. British Journal of Surgery 1991, 78, 797-801.
30. Steele G., Bleday R., Mayer R. J., Lindblad A., Petrelli N. and Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver - Gastrointestinal Tumor Study Group protocol-6584. Journal of Clinical Oncology 1991, 9, 1105-1112.
31. Lind D. S., Parker G. A., Horsley J. S., Kornstein M. J., Neifeld J. P., Bear H. D., et al. Formal hepatic resection of colorectal liver metastases - ploidy and prognosis. Annals of Surgery 1992, 215, 677-684.
32. Vanooijen B., Wiggers T., Meijer S., Vanderheijde M. N., Slooff M. J. H., Vandevelde C. J. H., et al. Hepatic resections for colorectal metastases in the Netherlands - a multiinstitutional 10-year study. Cancer 1992, 70, 28-34.
33. Nakamura S., Yokoi Y., Suzuki S., Baba S. and Muro H. Results of extensive surgery for liver metastases in colorectal carcinoma. British Journal of Surgery 1992, 79, 35-38.
34. Rosen C. B., Nagorney D. M., Taswell H. F., Helgeson S. L., Ilstrup D. M., Vanheerden J. A., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Annals of Surgery 1992, 216, 493-505.
35. Nordlinger, B., Jaeck, D., Guiget, M., Vaillant, J. C., Balladur, P. and Schaal, J. C. Surgical resection of hepatic metastases: multicentric retrospective study by the French Association of Surgery. In Treatment of Hepatic Metastases of Colorectal Cancer, ed. B. Nordlinger and D. Jaeck. Springer-Verlag, Paris, 1992, pp. 129-161.
36. Sugihara K., Hojo K., Moriya Y., Yamasaki S., Kosuge T. and Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. British Journal of Surgery 1993, 80, 1032-1035.
37. Pedersen I. K., Burcharth F., Roikjaer O. and Baden H. Resection of liver metastases from colorectal cancer-indications and results. Diseases of the Colon and Rectum 1994, 37, 1078-1082.
38. Gayowski T. J., Iwatsuki S., Madariaga J. R., Selby R., Todo S., Irish W., et al. Experience in hepatic resection for metastatic colorectal cancer - analysis of clinical and pathological risk factors. Surgery 1994, 116, 703-711.
39. Scott S., Carty N., Anderson L. and Taylor I. Liver resection for colorectal liver metastases. European Journal of Surgical Oncology 1995, 21, 33-35.
40. Doci R., Gennari L., Bignami P., Montalto F., Morabito A., Bozzetti F., et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. British Journal of Surgery 1995, 82, 377-381.
41. Jatzko G. R., Lisborg P. H., Stettner H. M. and Klimpfinger M. H. Hepatic resection for metastases from colorectal carcinoma - a survival analysis. European Journal of Cancer 1995, 31A, 41-46.
42. Little J. M. and Hollands M. Hepatic resection for colorectal metastases - selection of cases and determinants of success. Australia and New Zealand Journal of Surgery 1987, 57, 355-359.
43. Schwartz S. I. Hepatic resection for noncolorectal nonneuroendocrine metastases. World Journal of Surgery 1995, 19, 72-75.
44. Starzl T. E., Iwatsuki S., Shaw B. W., Waterman P. M., Van Thiel D., Diliz H. S., et al. Left hepatic trisegmentectomy. Surgical Gynecology and Obstetrics 1982, 155, 21-27.
45. Hardy K. J., Martin J., Fletcher D. R., Maclellan D. G. and Jones R. M. Hepatic resection - value of operative ultrasound and ultrasonic dissection. Australia and New Zealand Journal of Surgery 1989, 59, 621-623.
46. McDonald C. F. and Baird L. Risk of needle track metastasis after fine needle lung aspiration in lung cancer - a case report. Respiratory Medicine 1994, 88, 631-632.
47. Bradpiece H. A., Benjamin I. S., Halevy A. and Blumgart L. H. Major hepatic resection for colorectal liver metastases. British Journal of Surgery 1987, 74, 324-326.
48. Elias D., Detroz B., Lasser P., Plaud B. and Jerbi G. Is simultaneous hepatectomy and intestinal anastomosis safe?. American Journal of Surgery 1995, 169, 254-260.
49. Launois, B., Landen, S. and Heautot, J. F. Colorectal metastatic liver tumours. In Hepatobiliary Malignancy. Its Multidisciplinary Management, ed. J. Terblanche. Arnold, London, 1994, pp. 271-300.
50. Soyer P., Roche A., Elias D. and Levesque M. Hepatic metastases from colorectal cancer - influence of hepatic volumetric analysis on surgical decision making. Radiology 1992, 184, 695-697.
51. Ballantyne G. H. and Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993, 71, 4252-4266.
52. Tsao J. I., Loftus J. P., Nagorney D. M., Adson M. A. and Ilstrup D. M. Trends in morbidity and mortality of hepatic resection for malignancy - a matched comparative analysis. Annals of Surgery 1994, 220, 199-205.
53. Strong R. W., Lynch S. V., Wall D. R. and Ong T. H. The safety of elective liver resection in a special unit. Australia and New Zealand Journal of Surgery 1994, 64, 530-534.
54. Adson M. A. Resection of liver metastases - when is it worthwhile?. World Journal of Surgery 1987, 11, 511-520.
55. Steele G. and Ravikumar T. S. Resection of hepatic metastases from colorectal cancer. Annals of Surgery 1989, 210, 127-138.
56. Wagner J. S., Adson M. A., Vanheerden J. A., Adson M. H. and Ilstrup D. M. The natural history of hepatic metastases from colorectal cancer - a comparison with resective treatment. Annals of Surgery 1984, 199, 502-508.
57. Hughes K., Scheele J. and Sugarbaker P. H. Surgery for colorectal cancer metastatic to the liver optimizing the results of treatment. Surgical Clinics of North America 1989, 69, 339-359.
58. Younes R. N., Rogatko A. and Brennan M. F. The influence of intraoperative hypotension and peri-operative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Annals of Surgery 1991, 214, 107-113.
59. Cady B., Stone M. D., McDermott W. V., Jenkins R. L., Bothe A., Lavin P. T., et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Archives of Surgery 1992, 127, 561-569.
60. August D. A., Sugarbaker P. H., Ottow R. T., Gianola F. J. and Schneider P. D. Hepatic resection of colorectal metastases - influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Annals of Surgery 1985, 201, 210-218.
61. Greenway B. Hepatic metastases from colorectal cancer - resection or not? British Journal of Surgery 1988, 75, 513-519.
62. Lehnert T., Otto G. and Herfarth C. Therapeutic modalities and prognostic factors for primary and secondary liver-tumors. World Journal of Surgery 1995, 19, 252-263.
63. Hughes K. S. Resection of the liver for colorectal carcinoma metastases - a multi-institutional study of indications for resection. Surgery 1988, 103, 278-288.
64. Yamamoto J., Sugihara K., Kosuge T., Takayama T., Shimada K., Yamasaki S., et al. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Annals of Surgery 1995, 221, 74-78.
65. Hughes K. S., Simon R., Songhorabodi S., Adson M. A., Ilstrup D. M., Fortner J. G., et al. Resection of the liver for colorectal carcinoma metastases - a multi-institutional study of patterns of recurrence. Surgery 1986, 100, 278-284.
66. Ekberg H., Tranberg K. G., Andersson R., Lundstedt C., Hagerstrand I., Ranstam J., et al. Pattern of recurrence in liver resection for colorectal secondaries. World Journal of Surgery 1987, 11, 541-547.
67. Fortner J. G. Recurrence of colorectal cancer after hepatic resection. American Journal of Surgery 1988, 155, 378-382.
68. Franco D., Smadja C., Kahwaji F., Grange D., Kemeny F. and Traynor O. Segmentectomies in the management of liver tumors. Archives of Surgery 1988, 123, 519-522.
69. Fong Y., Blumgart L. H., Fortner J. G. and Brennan M. F. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Annals of Surgery 1995, 222, 426-437.
70. Stephenson K. R., Steinberg S. M., Hughes K. S., Vetto J. T., Sugarbaker P. H. and Chang A. E. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Annals of Surgery 1988, 208, 679-687.
71. Rougier P., Milan C., Lazorthes F., Fourtanier G., Partensky C., Baumel H., et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. British Journal of Surgery 1995, 82, 1397-1400.
72. Hohenberger P., Schlag P. M., Gerneth T. and Herfarth C. Preoperative and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases - predictive value and implications for adjuvant treatment based on multivariate analysis. Annals of Surgery 1994, 219, 135-143.
73. Wanebo H. J., Chu Q. D., Avradopoulos K. A. and Vezeridis M. P. Current perspectives on repeat hepatic resection for colorectal carcinoma: A review. Surgery 1996, 119, 361-371.
74. Hemming A. W. and Langer B. Repeat resection of recurrent hepatic colorectal metastases. British Journal of Surgery 1994, 81, 1553-1554.
75. Elias D., Lasser P., Hoang J. M., Leclere J., Debaene B., Bognel C., et al. Repeat hepatectomy for cancer. British Journal of Surgery 1993, 80, 1557-1562.
76. Nordlinger B., Vaillant J. C., Guiguet M., Balladur P., Paris F., Bachellier P., et al. Survival benefit of repeat liver resections for recurrent colorectal metastases - 143 cases. Journal of Clinical Oncology 1994, 12, 1491-1496.
77. Fong Y., Blumgart L. H., Cohen A., Fortner J. and Brennan M. F. Repeat hepatic resections for metastatic colorectal cancer. Annals of Surgery 1994, 220, 657-662.
78. Que F. G. and Nagorney D. M. Resection of recurrent colorectal metastases to the liver. British Journal of Surgery 1994, 81, 255-258.
79. Fernandeztrigo V., Shamsa F., Sugarbaker P. H., Hughes K. S., Scheele J., Stangl R., et al. Repeat liver resections from colorectal metastasis. Surgery 1995, 117, 296-304.
80. Lange J. F., Leese T., Castaing D. and Bismuth H. Repeat hepatectomy for recurrent malignant tumors of the liver. Surgical Gynecology and Obstetrics 1989, 169, 119-126.
81. Weaver M. L., Atkinson D. and Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995, 76, 210-214.
82. Ravikumar T. S., Steele G., Kane R. and King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Research 1991, 51, 6323-6327.
83. Charnley R. M., Thomas M. and Morris D. L. Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancer. Australia and New Zealand Journal of Surgery 1991, 61, 55-58.
84. Preketes A. P., King J., Caplehorn J. R. M., Clingan P. R., Ross W. B. and Morris D. L. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Australia and New Zealand Journal of Surgery 1994, 64, 612-614.
85. Morris D. L. and Ross W. B. Australian experience of cryoablation of liver tumors. Surgical Oncology Clinics of North America 1996, 5, 391-397.
86. Kane R. A. Ultrasound-guided hepatic cryosurgery for tumor ablation. Seminars in Interventional Radiology 1993, 10, 132-142.
87. Morris D. L., Horton M. D., Dilley A. V., Warlters A. and Clingan P. R. Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993, 34, 1156-1157.
88. Weaver M. L., Atkinson D. and Zemel R. Hepatic cryosurgery in the treatment of unresectable metastases. Surgical Oncology (Oxford) 1995, 4, 231-236.
89. Onik G., Rubinsky B., Zemel R., Weaver L., Diamond D., Cobb C., et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Cancer 1991, 67, 901-907.
90. Cozzi P. J., Stewart G. J. and Morris D. L. Thrombocytopenia after hepatic cryotherapy for colorectal metastases - correlates with hepatocellular injury. World Journal of Surgery 1994, 18, 774-777.
91. Ravikumar T. S., Kane R., Cady B., Jenkins R. L., McDermott W., Onik G., et al. Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Archives of Surgery 1987, 122, 403-409.
92. Ravikumar T. S. and Steele G. D. Hepatic cryosurgery. Surgical Clinics of North America 1989, 69, 433-440.
93. Polk W., Fong Y. M., Karpeh M. and Blumgart L. H. A technique for the use of cryosurgery to assist hepatic resection. Journal of the American College of Surgeons 1995, 180, 171-176.
94. McCall J. L., Jorgensen J. O. and Morris D. L. Laparoscopic hepatic cryotherapy - a study of safety in rabbits. Surgical Laparoscopy and Endoscopy 1996, 6, 29-31.
95. Preketes A. P., Caplehorn J. R. M., King J., Clingan P. R., Ross W. B. and Morris D. L. Effect of hepaticartery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World Journal of Surgery 1995, 19, 768-771.
96. Ravikumar T. S. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy: Invited commentary. World Journal of Surgery 1995, 19, 771.
97. Amin Z., Bown S. G. and Lees W. R. Local treatment of colorectal liver metastases - a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clinical Radiology 1993, 48, 166-171.
98. Livraghi T., Bolondi L., Buscarini L., Cottone M., Mazziotti A., Morabito A., et al. Treatment, resection and ethanol injection in hepatocellular carcinoma - a retrospective analysis of survival in 391 patients with cirrhosis. Journal of Hepatology 1995, 22, 522-526.
99. Livraghi T., Goldberg M. D., Lazzaroni S., Meloni F., Monti F. and Solbiati L. Saline enhanced RF tissue ablation in the treatment of liver metastases. Radiology 1995, 197, 140.
100. Griffin D. T., Dodd N. J. F., Zhao S., Pullan B. R. and Moore J. V. Low level direct electrical current therapy for hepatic metastases. 1. Preclinical studies on normal liver. British Journal of Cancer 1995, 72, 31-34.
101. Masters A., Steger A. C, Lees W. R., Walmsley K. M. and Bown S. G. Interstitial laser hyperthermia - a new approach for treating liver metastases. British Journal of Cancer 1992, 66, 518-522.
102. Amin Z., Donald J. J., Masters A., Kant R., Steger A. C., Bown S. G., et al. Hepatic metastases - interstitial laser photocoagulation with real time US monitoring and dynamic CT evaluation of treatment. Radiology 1993, 187, 339-347.
103. Vogl T. J., Muller P. K., Hammerstingl R., Weinhold N., Mack M. G., Philipp C., et al. Malignant liver tumors treated with MR imaging guided laser-induced thermotherapy technique and prospective results. Radiology 1995, 196, 257-265.
104. Thomas D. S., Nauta R. J., Rodgers J. E., Popescu G. F., Nguyen H. and Lee T. C., et al. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma - results of a phase I-II trial. Cancer 1993, 71, 1977-1981.
105. Armstrong J. G., Anderson L. L. and Harrison L. B. Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer 1994, 73, 1800-1804.
106. Gray B. N., Anderson J., Burton M. A. and Klemp P. Regression of liver metastases following treatment with yttrium-90 microspheres. Australia and New Zealand Journal of Surgery 1992, 62, 105-110.
107. Burton M. A. and Gray B. N. Adjuvant internal radiation therapy in a model of colorectal cancer derived hepatic metastases. British Journal of Cancer 1995, 71, 322-325.
108. Petrelli N. J., Barcewicz P. A., Evans J. T., Ledesma E. J., Lawrence D. D. and Mittelman A. Hepatic artery ligation for liver metastasis in colorectal carcinoma. Cancer 1984, 53, 1347-1353.
109. Wong K. T., Khir A. S. M., Noori S. and Peh S. C. Fatal haemoperitoneum due to rupture of hepatic metastases from renal cell carcinoma. Australia and New Zealand Journal of Surgery 1994, 64, 128-129.
110. Scheithauer W., Rosen H., Kornek G.-V., Sebesta C. and Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. British Medical Journal 1993, 306, 752-755.
111. Rougier, P., Lasser, P. and Elias, D. Chemotherapy of hepatic metastases of colorectal origin (systemic and local, in palliative or adjuvant treatment). In Treatment of Hepatic Metastases of Colorectal Cancer, ed. B. Nordlinger and D. Jaeck. Springer-Verlag, Paris, 1992, pp. 109-128.
112. Kerr D. J. and de Takats P. G. Chemotherapy for gastrointestinal cancer: teaching old drugs new tricks. Gastrointestinal Cancer 1995, 1, 3-7.
113. Cunningham D., Zalcberg J. R., Rath U., Olver I., Van-Cutsem E., Svensson C., et al. 'Tomudex' (ZD 1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group. European Journal of Cancer 1995, 31A, 1945-1954.
114. Hughes K. S. and Foster J. The role of adjuvant chemotherapy following curative hepatic resection of colorectal metastases. Proceedings of the American Society of Clinical Oncology 1991, 10, 145.
115. Vauthey J. N., Marsh R. D. E. W., Cendan J. C., Chu N. M. and Copeland E. M. Arterial therapy of hepatic colorectal metastases. British Journal of Surgery 1996, 83, 447-455.
116. Kemeny N. E. Regional chemotherapy of colorcctal cancer. European Journal of Cancer 1995, 31A, 1271-1276.
117. Rougier P., Laplanche A., Huguier M., Hay J. M., Ollivier J. M., Escat J., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. Journal of Clinical Oncology 1992, 10, 1112-1118.
118. Allen-Mersh T. G., Earlam S., Fordy C., Abrams K. and Houghton J. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 1994, 344, 1255-1260.
119. Wagman L. D., Kemeny M. M., Leong L., Terz J. J., Hill R. L., Beatty J. D., et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. Journal of Clinical Oncology 1990, 8, 1885-1893.
120. Kemeny N., Seiter K., Niedzwiecki D., Chapman D., Sigurdson E., Cohen A., et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992, 69, 327-334.
121. Kemeny N., Conti J. A., Cohen A., Campana P., Huang Y., Shi W. J., et al. Phase-II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. Journal of Clinical Oncology 1994, 12, 2288-2295.
122. Bismuth H., Adam R., Farahos C. H. and Levi F. Resection of unresectable hepatic metastases from colorectal cancer with neoadjuvant chronotherapy. European Journal of Cancer 1995, 31A, S209.
123. Lygidakis N. J., Ziras N. and Parissis J. Resection versus resection combined with adjuvant preoperative and postoperative chemotherapy - immunotherapy for metastatic colorectal liver cancer. Hepato-Gastroenterology 1995, 42, 155-161.
124. Moriya Y., Sugihara K., Hojo K. and Makuuchi M. Adjuvant hepatic intraarterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer - a pilot-study. European Journal of Surgical Oncology 1991, 17, 519-525.
125. Kimura T., Akazai Y., Iwagaki H., Nonaka Y., Ariki N., Fuchimoto S., et al. Metachronous liver metastasis of colorectal cancer - timing of occurrence and efficacy of adjuvant portal chemotherapy. Anticancer Research 1995, 15, 1585-1588.
126. Kemeny N., Conti J. A., Sigurdson E., Cohen A., Seiter K., Lincer R., et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin - a potential adjuvant program after resection of colorectal hepatic metastases. Cancer 1993, 71, 1964-1971.
127. Hodgson W. J. B., Mittelman A., Katz S., Friedland M., Berman H., Morgan J., et al. Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Annals of Surgery 1986, 203, 420-425.
128. Lang E. K. and Brown C. L. Colorectal metastases to the liver - selective chemoembolization. Radiology 1993, 189, 417-422.
129. Hunt T. M., Flowerdew A. D. S., Birch S. J., Williams J. D., Mullee M. A. and Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. British Journal of Surgery 1990, 77, 779-782.
130. Pichlmayr R., Weimann A., Oldhafer K. J., Schlitt H. J., Klempnauer J., Bornscheuer A., et al. Role of liver transplantation in the treatment of unresectable liver cancer. World Journal of Surgery 1995, 19, 807-813.
131. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991, 110, 726-735.
132. Hafstrom L. R., Holmberg S. B., Naredi P. L. J., Lindner P. G., Bengtsson A., Tidebrant G., et al. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surgical Oncology 1994, 3, 103-108.
133. Horikawa M., Nakajima Y., Kido K., Ko S., Ohashi K. and Nakano H. Simple method of hyperthermo-chemohypoxic isolated liver perfusion for hepatic metastases. World Journal of Surgery 1994, 18, 845-851.
134. Vahrmeijer A. L., Vandierendonck J. H. and Vandevelde C. J. H. Treatment of colorectal cancer metastases confined to the liver. European Journal of Cancer 1995, 31 A, 1238-1242.
135. Panis Y., Ribeiro J., Chretien Y. and Nordlinger B. Dormant liver metastases - an experimental-study. British Journal of Surgery 1992, 79, 221-223.
136. Savelieva E., Farace F., Angevin E., Elias D., Escudier B.. Duvillard P., et al. T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy. Journal of Immunotherapy 1994, 16, 66-76.
137. Elias D., Farace F., Triebel F., Hattchouel J. M., Pignon J. P., Lecesne A., et al. Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum. Journal of the American College of Surgeons 1995, 181, 303-310.
138. Zalcberg J. R., Pietersz G., Toohey B., Laird J., Huggins R., Zimet A. S., et al. A phase I/II study of the intralesional injection of ricin monoclonal antibody conjugates in patients with hepatic metastases. European Journal of Cancer 1994, 30A, 1227-1231.
139. Welt S., Divgi C. R., Scott A. M., Garin-Chesa P., Finn R. D., Graham M., et al. Antibody targeting in metastatic colon cancer: A phase i study of monoclonal antibody F19 against a cell surface protein of reactive tumor stromal fibroblasts. Journal of Clinical Oncology 1994, 12, 1193-1203.
140. Takahashi H., Nakada T., Nakaki M. and Wands J. R. Inhibition of hepatic metastases of human colon cancer in nude mice by a chimeric SF-25 monoclonal antibody. Gastroenterology 1995, 108, 172-182.
141. Schlag P., Manasterski M., Gerneth T., Hohenberger P., Dueck M., Herfarth C., et al. Active specific immunotherapy with Newcastle disease virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer - 1st evaluation of clinical response of a phase II-trial. Cancer Immunology and Immunotherapy 1992, 35, 325-330.
142. Wang B., Merva M., Dang K. S., Ugen K. E., Williams W. V. and Weiner D. B. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Human Gene Therapy 1995, 6, 407-418.
143. van-Eijck C. H., Slooter G. D., Hofland L. J., Kort W., Jeekel J., Lamberts S. W., et al. Somatostatin receptor dependent growth inhibition of liver metastases by octreotide. British Journal of Surgery 1994, 81, 1333-1337.
144. Qin Y., van Cauteren M., Osteaux M., Serially A. V. and Willems G. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: A study with magnetic resonance imaging. Cancer Research 1992, 52, 6025-6030.
145. Konno H., Tanaka T., Matsuda I., Kanai T., Maruo Y., Nishino N., et al. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. International Journal of Cancer 1995, 61, 268-271.
146. Geraghty P. J. and Chang A. E. Basic principles associated with gene therapy of cancer. Surgical Oncology 1995, 4, 125-137.
147. Habib N. A., Ding S. F., Elmasry R., Mitry R. R., Honda K. and Michail N. E. Preliminary report - The short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detection and Prevention 1996, 20, 103-107.
148. Fearon E. R., Pardoll D. M., Itaya T., Golumbek P., Levitsky H. I. and Simons J. W. Interleukin-2 production by tumor cells bypasses T-helper function in the generation of an antitumor response. Cell 1990, 60, 397-403.
149. Caruso M., Panis Y., Gagandeep S., Houssin D., Salzmann J.-L. and Klatzmann D. Regression of established macroscopic liver metastases after in-situ transduction of a suicide gene. Proceedings of the National Academy of Sciences, U.S.A. 1993, 90, 7024-7028.